Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Mar 20, 2024
- Accession no.
- 0001415889-24-008770
- Filed
- Mar 20, 2024
- Trade date
- Mar 18, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $908.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Common Stock | MOption exerciseAcquired | +20,557 | $2.14 | +$43,991.98 | 21,848 | Direct | |
| Mar 18, 2024 | Common Stock | MOption exerciseAcquired | +14,500 | $10.61 | +$153,845 | 36,348 | Direct | |
| Mar 18, 2024 | Common Stock | SSaleDisposed | −27,476 | $25.74 | −$707,232.24 | 8,872 | Direct | |
| Mar 18, 2024 | Common Stock | SSaleDisposed | −7,581 | $26.48 | −$200,744.88 | 1,291 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Common Stock | MOption exerciseDisposed | −20,557 | $0.00 | $0 | 102,789 | Direct | |
| Mar 18, 2024 | Common Stock | MOption exerciseDisposed | −14,500 | $0.00 | $0 | 43,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.